Home

overview

Congenital adrenal hyperplasia (CAH) is a rare genetic disorder affecting adrenal steroidogenesis, with an estimated global incidence of 1 in 10,000 to 15,000 live births. CAH imposes a significant burden to patients due to life-long management, frequent medical monitoring, and risks of adrenal crises. Furthermore, delays in diagnosis, access to specialized care, and limited treatment options contribute to poor outcomes, underscoring the need for improved care systems for patients with CAH. [break] [break] Join us for this engaging virtual race where our panel of experts will present real world clinical scenarios and request audience input on clinical decisions focusing on the diagnosis, management, and treatment of CAH, including the latest data on novel treatment options and where they may fit into the therapeutic armamentarium. Which team will cross the finish line first? [break] [break] Please note: You must be registered for ENDO 2025 in order to attend the symposium in-person.

This independent, supported Satellite Symposia is not part of the ENDO 2025 official educational programming as planned by the Endocrine Society Annual Meeting Steering Committee. This program is neither sponsored nor endorsed by the Endocrine Society. The information presented here has not been reviewed or approved by the Endocrine Society for accuracy or completeness, and the views expressed in this presentation are those of the presenters and do not represent the views of the Endocrine Society. This program may offer continuing medical education (CME) or MOC credit provided by the sponsoring organization.

faculty

CHAIRPERSON

Richard J. Auchus, MD, PhD, FACE

The James A. Shayman and Andrea S. Kevrick Professor of Translational Medicine

Division of Metabolism, Endocrinology and Diabetes

Departments of Internal Medicine and Pharmacology

University of Michigan Medical School

Ann Arbor, Michigan, United States

SPEAKER

Henrik Falhammar, MD, PhD, FRACP

Associate Professor

Senior Consultant Endocrinologist and General Physician

Director of Research and Education

Department of Endocrinology

Karolinska University Hospital

Department of Molecular Medicine and Surgery

Karolinska Institutet

Stockholm, Sweden

SPEAKER

Patricia Y. Fechner, MD

Professor of Pediatrics

University of Washington School of Medicine

Medical Director

Seattle Children's CAH Center of Excellence

Seattle, Washington, United States

AGENDA

7:00 PM TZ

Registration and Dinner

7:30 PM TZ

Welcome and Introductions

7:35 PM TZ

Neonatal and Pediatric Management of CAH

8:00 PM TZ

Managing CAH in Adulthood and Transition of Care

8:20 PM TZ

Managing CAH in Pregnancy and Family Planning

8:35 PM TZ

Panel Discussion and Q&A

TARGET AUDIENCE

This educational activity is intended for an audience of endocrinologists, primary care physicians, pediatricians, nurse practitioners, physician assistants, and other medical professionals managing CAH in the United States.

GOAL STATEMENT

The goal of this activity is for learners to be better able to optimize treatment of patients with CAH according to the latest clinical evidence.

LEARNING OBJECTIVES

Upon completion of this activity, participants will: [break] [break] Have increased knowledge regarding the [list][item]Recent advances in management of CAH [break] [break] [/list]Have greater competence related to: [list][item]Identification of patients struggling with CAH management [item]Appropriately using advances in CAH management in classic patients [item]Patient/care partner/family education and engagement in those affected by CAH

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[bold]For Physicians[/bold] [break] Medscape, LLC designates this live activity for a maximum of 1.25 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [break] [break] [bold]For Nurses[/bold] [break] Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs.

A 360-Degree Look at Comprehensively Managing Congenital Adrenal Hyperplasia CME/CNE